tiadenol has been researched along with Carbohydrate Inducible Hyperlipemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battistin, P; Colli, S; Gianfranceschi, G; Maderna, P; Malacrida, MG; Montanari, G; Morazzoni, G; Sirtori, CR; Sirtori, M; Tremoli, E | 1 |
| Colombo, L; Goldberg, D; Monarca, A; Zanetta, R | 1 |
1 trial(s) available for tiadenol and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
Clofibrate and tiadenol treatment in hyperlipoproteinemias. A comparative trial of drugs affecting lipoprotein catabolism and biosynthesis.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Clofibrate; Fatty Alcohols; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Uric Acid | 1983 |
1 other study(ies) available for tiadenol and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
[Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
Topics: Clofibrate; Fatty Alcohols; Gastrointestinal Diseases; Headache; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Muscular Diseases; Pain | 1979 |